Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis

OBJECTIVE: To estimate the association between the use of sodium glucose co-transporter-2 (SGLT2) inhibitors and postmarket harms as identified by drug regulatory agencies. DESIGN: We conducted a systematic review and meta-analysis of randomised controlled trials (RCT). Six large databases were sear...

Descripción completa

Detalles Bibliográficos
Autores principales: Donnan, Jennifer R, Grandy, Catherine A, Chibrikov, Eugene, Marra, Carlo A, Aubrey-Bassler, Kris, Johnston, Karissa, Swab, Michelle, Hache, Jenna, Curnew, Daniel, Nguyen, Hai, Gamble, John-Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361337/
https://www.ncbi.nlm.nih.gov/pubmed/30813108
http://dx.doi.org/10.1136/bmjopen-2018-022577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361337/
https://www.ncbi.nlm.nih.gov/pubmed/30813108
http://dx.doi.org/10.1136/bmjopen-2018-022577

Ejemplares similares